ALL Clinical Trial
Official title:
Massage Therapy vs. Music Therapy vs. Usual Care in an Inpatient Setting: A Pilot Study
This project studies the feasibility of (1) implementing massage therapy and music therapy onto a busy medical inpatient unit at Boston Medical Center, and (2) evaluating massage therapy and music therapy's impact on patient satisfaction, patient outcomes, and cost. The investigators will conduct a randomized controlled trial comparing massage therapy, music therapy, and usual care to collect preliminary data on critical outcomes for patients (satisfaction, symptom control) and for the hospital (pain medication use and length of stay, both critical drivers of cost). The investigators anticipate using these preliminary data to apply for a future larger and longer adequately powered randomized controlled trial to definitively answer the following research questions: does implementation of an inpatient massage therapy and/or music therapy service (a) improve patient satisfaction; (b) reduce symptoms such as pain; and (c) lower health care costs through less pain medication and reduced length of stay?
This randomized controlled trial compares massage therapy to usual care and music therapy to
usual care for patients admitted to the Family Medicine Inpatient Unit of Boston Medical
Center. Ninety family medicine inpatients will be recruited by the research assistant to
participate in the study. Participants will be randomized directly following consent in a
1:1:1 ratio to massage therapy, music therapy, or usual care. Individuals assigned to the
usual care group will receive the choice of a massage voucher for one massage at Boston
Medical Center's Integrative Medicine program or a music therapy CD following completion of
the study.
Treatment assignments will be prepared by the study biostatistician, using a permuted block
method with varying block sizes of 3, 6, and 9, prior to the start of the study. These will
be sealed in sequentially numbered opaque envelopes. This order will not be changed. A
research assistant will take a randomization envelope, in sequential order, and read the
treatment assignment to the participant following enrollment.
After enrollment and randomization is complete each day, the massage therapist and music
therapist will begin to see participants for treatment. Treatments will take place in the
inpatient hospital room. Curtains will be pulled closed to maintain privacy in rooms that
have two beds. Both music and massage therapists will be present Monday-Sunday to provide
treatment to participants.
Treatments will be attempted 1-3 times per day for the duration of the participant's stay on
the unit, based on the participant's availability (they may be scheduled for diagnostic
tests, imaging, consults, etc). The music and massage therapists will work down the list of
participants, visiting each one by one and administering treatment (details below for each
therapy). If a participant is not available at the time the therapist comes by, he/she will
revisit the participant after they have gone through their list and administered treatments.
Once the therapist has provided the therapy once to every patient on his/her list, he/she
will begin at the top of the list and provide a second round of treatments, and repeat again
for a third round as time permits.
The music therapist and massage therapist will create a note sheet each day for each
participant. This will allow them to track number of treatments as well as any comments
relevant to treatment (patient preferences, etc). A research assistant will collect these at
the end of each day, enter them into the secure online database, and store them in a locked
file cabinet.
The music therapist and massage therapist will each be given an updated list of patients to
treat (first name, last initial, room number) each morning. These lists (separated by
treatment group) will include the newly enrolled and randomized participants as well as
those who have not yet been discharged. At the end of each day, the therapists will report
to the research assistant on how many sessions were provided to each participant.
When the research assistant notes that a participant has been discharged, he/she has
approximately 7 days to contact the patient (by phone or email) to administer the endline
survey. Then, thirty days after discharge, the research assistant will check the
participant's electronic medical record to see if he/she has been admitted again since
discharge. Participants in the control group, following discharge and completion of the
endline survey, will be mailed either a music/meditation CD or a voucher for massage at BMC,
according to their preference.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05016947 -
Venetoclax Plus Inotuzumab for B-ALL
|
Phase 1 | |
Recruiting |
NCT05009537 -
Optical Genome Mapping in Hematological Malignancies
|
||
Terminated |
NCT01230788 -
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia
|
N/A | |
Completed |
NCT00333190 -
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT05461625 -
ACL Reconstruction With/Without ALL Reconstruction
|
N/A | |
Recruiting |
NCT02990572 -
Amish/Mennonite Research Contact Registry
|
||
Completed |
NCT02631993 -
Photochemotherapy and Graft-versus-leukemia in Acute-leukemia
|
N/A | |
Completed |
NCT00863148 -
Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)
|
Phase 2 | |
Recruiting |
NCT04601584 -
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05592470 -
commd7 Gene Expression in ALL
|
||
Recruiting |
NCT02861209 -
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
|
N/A | |
Completed |
NCT01012492 -
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
|
Phase 2 | |
Recruiting |
NCT04644016 -
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
|
Phase 2 | |
Recruiting |
NCT06131801 -
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
|
||
Recruiting |
NCT05476770 -
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
|
Phase 1 | |
Recruiting |
NCT03571321 -
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
|
Phase 1 | |
Recruiting |
NCT05414162 -
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
|
||
Active, not recruiting |
NCT03154346 -
Project Baseline Health Study
|
||
Terminated |
NCT01532635 -
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
|
Phase 2 | |
Completed |
NCT01319864 -
POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
|
Phase 1 |